NTRR Considers Cannabis Cures for the Common Cold


NTRR Considers Cannabis Cures for the Common Cold

TAMPA, Fla.--(BUSINESS WIRE)-- As more and more North American markets approve the legalization of cannabis for medicinal and therapeutic purposes, Neutra Corp. (OTCBB: NTRR) is exploring the potential for new natural remedies derived from the misunderstood plant.

The benefits of cannabis in the treatment of maladies from glaucoma to nausea have long been understood, But with many new markets now opening up, cannabinoids—the key chemical compounds found in marijuana plants—are now being tested in topical ointments, pills and other treatments to cure everything from skin ailments to digestive issues.

"In many ways, cannabis may prove to be the ultimate nutraceutical," said NTRR CEO Cindy Morrissey. "Our company is tremendously excited to explore cannabinoids' natural potential to ease suffering, especially because the market for such remedies is booming from California to Massachusetts."

Neutra Corp. plans to follow in the footsteps of other successful public companies, including Cannibis Science, Inc. (OTCBB: CBIS) and Terra Tech Corp. (OTCBB: TRTC), enabling agricultural advancements in the urban cultivation of cannabis in approved markets.

"We're ready to put the healing potential of cannabis into the hands of those who need it most," Morrissey said.

The company is also pursuing innovations in anti-microbial coatings for surfaces in hospitals and other public spaces. Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing wellness sector alongside Herbalife Ltd. (NYS: HLF) and Nutraceutical International Corp. (NAS: NUTR) .

For more information on NTRR's nutraceuticals initiative, please visit www.neutracorp.com/investors.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions. The company is currently working to produce a full range of non-toxic products to address every component of a healthy lifestyle. For investing information and performance data, please visit www.neutracorp.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Cindy Morrissey, 713-821-1486
President and CEO

KEYWORDS: United States North America Florida


The article NTRR Considers Cannabis Cures for the Common Cold originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.